Top 88 alternative sites to cgoncology.com
-
adaptimmune.com
-
zelluna.com
-
vaccibody.com
-
biolinerx.com
-
celyad.com
-
cardiffoncology.com
-
bellicum.com
-
tessacell.com
-
bioeclipse.com
-
betapharma.com
-
humanigen.com
-
imv-inc.com
-
abcentra.com
-
blackthornrx.com
-
helixbiopharma.com
-
ikenaoncology.com
-
verastem.com
-
epirium.com
-
geron.com
-
oysterpointrx.com
-
ampiopharma.com
-
epizyme.com
-
harpoontx.com
-
lanternpharma.com
-
kiorapharma.com
-
immutep.com
-
cariboubio.com
-
surfaceoncology.com
-
eurekatherapeutics.com
-
wjon.org
-
oncdata.com
-
litevax.com
-
akaalpharma.com
-
synimmune.de
-
beigene.com
-
desentum.fi
-
atossatherapeutics.com
-
ijcto.org
-
bjeaglesky.com
-
ocugen.com
-
ascopubs.org
-
medelis.com
-
ableads.fr
-
khondrion.com
-
trioncology.org
-
jubilanttx.com
-
adctherapeutics.com
-
regenesys.eu
-
newron.com
-
td2inc.com
-
cellectis.com
-
connectbiopharm.com
-
claritypharmaceuticals.com
-
neovii.com
-
asuragen.com
-
trevena.com
-
bionomics.com.au
-
formatherapeutics.com
-
genelux.com
-
ocuphire.com
-
mtem.com
-
astellasoncology.com
-
zymeworks.com
-
oculis.com
-
theoncologygroup.com
-
itoc-conference.eu
-
pharnext.com
-
rkaufman.free.fr
-
incyte.com
-
amunix.com
-
iwirc.com
-
ltcreit.com
-
mozart-tx.com
-
eurekaconnectme.com
-
bluefieldproject.org
-
neoleukin.com
-
vir.bio
-
dynavax.com
-
zosanopharma.com
-
plexxikon.com
-
novomedix.com
-
blademed.com
-
nkartatx.com
-
americancollegeofbankruptcy.com
-
tempesttx.com
-
cpii.com
-
ultragenyx.com
-
allakos.com
Adaptimmune Therapeutics plc
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
Home - Vaccibody.com
Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies
Home | BioLineRx
BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.
Home - Celyad Oncology
ABOUT CELYAD ONCOLOGY Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor
Author: Celyad Oncology
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Home - Bellicum Pharmaceuticals, Inc. : Bellicum Pharmaceuticals, Inc.
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
BioEclipse Therapeutics™ | NEXT GENERATION OF IMMUNOTHERAPY
BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics.
Beta Pharma | Oncology research and oncology **** development
Beta Pharma | Dedicated to innovative late stage oncology research and oncology **** development
Humanigen, Inc.
We are a clinical stage biopharmaceutical company, developing our immunology and immuno-oncology portfolio of monoclonal antibodies.
IMV Inc.
IMV Inc. is a clinical-stage biopharmaceutical company developing a new class of cancer immunotherapies and vaccines against infectious diseases
Abcentra - Therapeutics
Abcentra is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for cardiovascular and inflammatory diseases.
Neurobehavioral Disorder **** Development | BlackThorn Therapeutics
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company developing novel, targeted treatments for neurobehavioral disorders. Learn more.
Helix BioPharma - New Directions in Cancer Therapy
We are a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on our proprietary technological platform.
Ikena Oncology | Biomarker-Driven Cancer Therapeutics
Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.
Author: Walid
Verastem Oncology | Biopharmaceutical Company
Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company committed to the development of medicines to improve the lives of patients diagnosed with cancer.
Epirium Bio
Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Imetelstat | Myelofibrosis | Myelodysplastic Syndrome | Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Other sites like cgoncology com
Oyster Point Pharma - Therapies to Address Ophthalmic Disease
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease.
Ampio Pharmaceuticals
A development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options.
Home - Epizyme
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Harpoon Therapeutics | Immuno-oncology | TriTAC™
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases.
Lantern Pharma Inc - Precision Oncology Medicine
Lantern Pharma is an emerging, oncology-focused, clinical stage pharma at the intersection of Artificial Intelligence, Genomics, and Machine Learning.
Author: Panna Sharma
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma - Kiora Pharmaceuticals
WALTHAM, MA, December 21, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical stage company focused on developing products for treating disorders of the eye, today announced the acquisition of Panoptes Pharma (“Panoptes”), a privately-held clinical stage biotech company focused on developing a novel proprietary small molecule for the treatment […]
Author: Kioradev
LAG-3 - Effective Cancer Immunotherapy | Immutep
Immutep is a leading biotechnology company focused on developing effective autoimmune and cancer immunotherapy treatments such as Lag-3.
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Surface Oncology | Break Through
Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.
Eureka Therapeutics | ARTEMIS™ | E-ALPHA® | T-cell therapies
Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
World Journal of Oncology
World Journal of Oncology - Basic Research and Clinical Investigation
Author: Aneesha Choudary Gummadi; Achuta Kumar Guddati
Oncology Data Advisor - Oncology and Hematology News for the Cancer Treatment Team
Our mission is to keep readers informed about the latest advances in oncology research and clinical care. Original content includes thought leader interviews on groundbreaking developments from late-stage trials, expert insights into supportive care best practices, oncology conference highlights and analysis, health care practice gap research, breaking news stories on FDA approvals, and more!
Welcome to LiteVax
LiteVax BV is a biopharmaceutical company focusing on the development and exploitation of novel adjuvant concepts.
Akaal Pharma Pty Ltd | clinical-stage **** discovery and development
Akaal Pharma is a clinical-stage **** discovery and development company focused on developing novel drugs for the treatment of inflammatory diseases.
SYNIMMUNE GmbH: Welcome
SYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy of.
BeiGene | Developing the Next Generation of Cancer Treatments
BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology **** candidates for the treatment of cancer.
Desentum
Desentum is a biopharmaceutical company developing novel types of allergen immunotherapy products (allergy vaccines) that actually change the way the immune system reacts to allergens.
Author: Super User
Atossa Therapeutics - A Clinical-Stage Biopharmaceutical Company
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on **** cancer treatment and other **** conditions.
International Journal of Cancer Therapy and Oncology
Clinical cancer research in radiation oncology, clinical medical physics, radiation therapy, cancer biology, cancer science and therapeutics, cancer detection and prevention, cancer nanotechnology, medical oncology, and clinical oncology
Bepotastine besylate|Febuxostat|Eagle Sky PharmaTech
Eagle Sky PharmaTech is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs. The company has developed an...
What else cgoncology.com alternative websites
Ocugen, Inc. – Pursuing Innovative Ocular Biotherapeutics
Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
Journal of Clinical Oncology
Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to the care of patients with cancer.
Author: Ramalingam et al
Oncology CRO
Medelis is a specialty oncology CRO - contract research organization - providing oncology **** development services for biotech / pharma sponsors seeking rapid **** development.
AbLeads - Potent New Cancer Treatments from Precision Immunotherapy
AbLeads is an Oncology biotech startup developing powerful new cancer treatments combining Immunotherapy and Precision Medicine. Discover our project!
Home - Khondrion
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
Cancer Research | Translational Research In Oncology
Translational Research In Oncology (TRIO) is a clinical cancer research organization working to save lives through innovative cancer research.
Jubilant Therapeutics | Oncology | Autoimmune
As a patient-centric biopharmaceutical company, Jubilant Therapeutics leverages innovation to address unmet medical needs in oncology and autoimmune diseases.
Antibody **** Conjugates Cancer Treatment – ADC Therapeutics
ADC Therapeutics is a commercial-stage oncology-focused biotechnology company developing ADCs.
ReGenesys bvba
ReGenesys is a biopharmaceutical company focused on the research and development of stem cell based therapies.
Author: Regenesys Bvba
Homepage | Newron Pharmaceuticals
We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system
Leading Oncology Research – TD2
TD2, a leading oncology CRO, advances oncology research by guiding pharmaceutical and biotechnology therapies from preclinical and clinical trial phases to FDA approval.
Home | Cellectis
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer
Connect Biopharma - Next-Generation Therapeutics for T Cell-Driven Inflammatory Diseases
Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics
Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
Homepage - Welcome to biopharmaceutical company NEOVII
Homepage - NEOVII Neovii is a biopharmaceutical company, focused on **** transplantation and hematology/oncology.
Asuragen: Genetics and Oncology Testing Products, MolecularDx Controls | Asuragen
Asuragen is a global diagnostic products company delivering genetics and oncology products that address unmet needs for clinical research and laboratories.
Trevena, Inc. (TRVN)
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions.
Home | Bionomics – Clinical-stage biopharmaceutical company
Bionomics is a global, clinical-stage biopharmaceutical company focusing on unmet needs such as anxiety and PTSD, cognitive impairment and other CNS disorders.
Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Genelux Corporation
BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics.
Other websites similar as cgoncology.com
Ocuphire Pharma, Inc. (OCUP)
Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company developing and commercializing therapies for the treatment of eye disorders.
Molecular Templates, Inc. (MTEM)
Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
Astellas Oncology
Astellas Oncology, a division of Astellas Pharma, is focused on developing innovative, targeted therapies for hard-to-treat cancers.
Zymeworks
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
Oculis |
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and the lives of patients worldwide.
Home | The Oncology Group
Oncology clinical and administrative professionals offering consulting services to help develop and expand your cancer program.
ITOC | ITOC8 8th Immunotherapy of Cancer Conference
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology **** development and delivery.
Pharnext - Pharnext
Pharnext is an advanced clinical-stage biopharmaceutical company developing novel first-in-class therapies for orphan and common diseases with high unmet medical needs, leveraging our artificial intelligence (AI)-based PLEOTHERAPY™ platform.
covance undercover | covance undercover video | PETA covance investigation
Covance is a comprehensive, biopharmaceutical **** development services company with preclinical and clinical research operations across the globe.
Biopharmaceutical Company | Solutions for Unmet Medical Needs | Incyte.com
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines..
Some websites with similar theme to cgoncology.com include:
XPAT® | Pro-XTEN Platform | T Cell Engagers | Amunix Pharmaceuticals
Amunix is an immuno-oncology company leveraging Pro-XTEN technology platform to discover and develop transformative therapies for patients with cancer.
IWIRC, International Women's Insolvency & Restructuring Confederation
IWIRC, the premier networking organization for women in the practice of insolvency and restructuring, helps its members achieve productive relationships by providing a range of practice development and networking opportunities that enhance their professional stature within an open and friendly culture.
Financing Senior Housing Since 1992 | LTC Properties Inc.
LTC Properties is a REIT investing in seniors housing and health care through sale-leasebacks, mortgage financing, joint-ventures, construction financing and structured finance solutions.
Mozart Therapeutics | CD8 T regulatory cells | Autoimmune and Inflammatory diseases
Mozart Therapeutics is capitalizing on a novel CD8 T regulatory cell network to develop innovative disease-modifying therapies for autoimmune and inflammatory diseases.
Liver Cancer & T-Cell Therapy | Eureka Connect Me
Learn more about liver cancer and our unique approach to tackling liver cancer at Eureka Connect Me.
Frontotemporal dementia | The Bluefield Project to Cure FTD
The Bluefield Project was established in 2010 to fund research directed towards curing frontotemporal dementia (FTD). FTD is a devastating, early-onset degenerative brain disease and is recognized as a common cause of dementia in people under the age of 60 years.
The Protein Design Revolution Begins Here
Neoleukin is a leader in de novo protein design – utilizing advanced computational methods to build entirely new therapeutic proteins tailor-made to treat immunological disorders, including cancer and autoimmunity.
Vir Biotechnology
Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Dynavax Technologies | Toll-like Receptor | Vaccines
Dynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
Zosano Pharma | Migraine treatment | M207 | zolmitriptan
Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy.
More other alternatives for cgoncology com
Engineering Drugs for Personalized Medicines
Engineering Drugs for Personalized Medicines, Plexxikon has earned a reputation as a leader in targeted **** discovery and translational, personalized medicine.
NovoMedix LLC
NovoMedix is conquering Cancer and Fibrosis by IL-11 inhibition and modulation of key regulatory pathways
Blade Therapeutics
Blade Therapeutics is advancing innovative anti-fibrotic therapies to meet currently unserved patient needs.
Natural Killer Cells (NK Cells) for the treatment of cancer
Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.
American College of Bankruptcy
The mission of the College is to honor and recognize distinguished bankruptcy professionals who are qualified for membership in an effort to set standards of achievement for others in the insolvency community.
Innovative Targeted and Immune-Mediated Cancer Therapies
Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients.
Communications & Power Industries
Communications & Power Industries (CPI) provides microwave, radio frequency (RF), power and control solutions for defense, communications, medical, scientific and industrial applications. Products include: VEDs, klystrons, TWTs, TWTAs, CFAs, satcom amplifiers, HPAs, SSPAs, LNAs, LNBs, power grid devices, advanced antenna systems, BUCs, solid-state devices, IMAs, EIKs, magnetrons, gyrotrons, medical x-ray generators, medical digital imaging systems, telemetry systems, radomes, transmitters, microwave switches, RF decks, receiver protectors, pressure windows, helix devices, coupled cavity devices
Rare Genetic Diseases | Ultragenyx
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.
Allakos | AK002 mAb
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases
